Halozyme CEO Helen Torley
Roche's Chugai lines up a $185M deal to switch drug candidate to subcutaneous formulation
Back in the spring of 2020, J&J and its partner on the big multiple myeloma drug Darzalex announced a big improvement for the program after …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
